Health Condition 1: R978- Other abnormal tumor markers
Conditions
Interventions
Intervention1: Randomized Control Trial: Intervention group: Patients undergoing advanced oncological procedures (Cytoreductive Surgery, Intra abdominal carcinoma ETC) Will receive parenteral glutamin
Sponsors
Aster CMI Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age greater than or equal to 18 years. Undergoing elective advanced cancer surgery - Gastrointestinal cancer surgery - Hepatopancreatobiliary - Gynecologic including - Peritoneal surface malignancy including CRS HIPEC - Thoracic cancer surgery Informed consent provided
Exclusion criteria
Exclusion criteria: Exclusion criteria: Known allergy or intolerance to glutamine. Severe hepatic or renal dysfunction. Participation in another interventional study. Emergency surgeries.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study may provide robust evidence on the efficacy of parenteral glutamine in reducing postoperative complications, potentially shaping nutritional protocols in oncologic surgery and improving patient outcomes. This Comparative analysis between Glutamine supplementation and no additional supplementation will give us the exact effect of glutamine on post operative recovery.Timepoint: Baseline, 1 week, Post surgery, 1month post surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Ashwin K R
Aster CMI Hospital
Outcome results
None listed